Mylan stock popped Thursday after the Food and Drug Administration tentatively approved its generic version of Eli Lilly's chemotherapy, Alimta. Lilly stock also rose in afternoon action.

source https://finance.yahoo.com/m/18dcb71f-60e5-34a9-ac25-8612f8dce369/mylan-stock-leaps-as-it.html?.tsrc=rss